Cargando…
LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
BACKGROUND: Low molecular weight protein tyrosine phosphatase (LMW-PTP) is overexpressed in different cancer types and its expression is related to more aggressive disease, reduced survival rate and drug resistance. Morin is a natural polyphenol which negatively modulates, among others, the activity...
Autores principales: | Capitani, Nagaja, Lori, Giulia, Paoli, Paolo, Patrussi, Laura, Troilo, Arianna, Baldari, Cosima T., Raugei, Giovanni, D’Elios, Mario Milco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429822/ https://www.ncbi.nlm.nih.gov/pubmed/30948927 http://dx.doi.org/10.1186/s12935-019-0786-1 |
Ejemplares similares
-
Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells
por: Cattaneo, Francesca, et al.
Publicado: (2016) -
Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia
por: Patrussi, Laura, et al.
Publicado: (2021) -
P66Shc: A Pleiotropic Regulator of B Cell Trafficking and a Gatekeeper in Chronic Lymphocytic Leukemia
por: Patrussi, Laura, et al.
Publicado: (2020) -
Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
por: Lori, Giulia, et al.
Publicado: (2018) -
Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment
por: Capitani, Nagaja, et al.
Publicado: (2021)